相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Adiponectin: A multitasking player in the field of liver diseases
T. E. Silva et al.
DIABETES & METABOLISM (2014)
High-Fat Diet Induces Leptin Resistance in Leptin-Deficient Mice
C. E. Koch et al.
JOURNAL OF NEUROENDOCRINOLOGY (2014)
Lactobacillus rhamnosus GG Protects against Non-Alcoholic Fatty Liver Disease in Mice
Yvonne Ritze et al.
PLOS ONE (2014)
Effects of glutamine on oxidative stress and nuclear factor-κB expression in the livers of rats with nonalcoholic fatty liver disease
Zhihui Lin et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2014)
Relationship Between Visceral Adipose Tissue and Adiponectin, Inflammatory Markers and Thyroid Hormones in Obese Males with Hepatosteatosis and Insulin Resistance
Fatih Ozcelik et al.
ARCHIVES OF MEDICAL RESEARCH (2013)
Gender differences in the association of visceral and subcutaneous adiposity with adiponectin in African Americans: the Jackson Heart Study
Aurelian Bidulescu et al.
BMC CARDIOVASCULAR DISORDERS (2013)
Gut microbiota and non-alcoholic fatty liver disease: new insights
J. Aron-Wisnewsky et al.
CLINICAL MICROBIOLOGY AND INFECTION (2013)
Proinflammatory, anti-inflammatory cytokines and adiponkines in students with central obesity
Amany El-Wakkad et al.
CYTOKINE (2013)
The expanding role of fish models in understanding non-alcoholic fatty liver disease
Yoichi Asaoka et al.
DISEASE MODELS & MECHANISMS (2013)
Dietary quercetin ameliorates nonalcoholic steatohepatitis induced by a high-fat diet in gerbils
Hua-Zhong Ying et al.
FOOD AND CHEMICAL TOXICOLOGY (2013)
Association of the+45T>G adiponectin gene polymorphism with insulin resistance in non-diabetic Saudi women
Amal Mohammed Husein Mackawy
GENE (2013)
Genetic association of ADIPOQ gene variants with type 2 diabetes, obesity and serum adiponectin levels in south Indian population
Kandaswamy Ramya et al.
GENE (2013)
Toll-Like Receptor 2 and Palmitic Acid Cooperatively Contribute to the Development of Nonalcoholic Steatohepatitis Through Inflammasome Activation in Mice
Kouichi Miura et al.
HEPATOLOGY (2013)
Serum biomarkers in type 2 diabetic patients with non-alcoholic steatohepatitis and advanced fibrosis
Nathalie Carvalho Leite et al.
HEPATOLOGY RESEARCH (2013)
Inflammation as a potential link between nonalcoholic fatty liver disease and insulin resistance
Mohamed Asrih et al.
JOURNAL OF ENDOCRINOLOGY (2013)
Adiponectin Gene Variant Interacts with Fish Oil Supplementation to Influence Serum Adiponectin in Older Individuals
Aseel AlSaleh et al.
JOURNAL OF NUTRITION (2013)
Rosuvastatin ameliorates high-fat and high-cholesterol diet-induced nonalcoholic steatohepatitis in rats
Yoshihisa Okada et al.
LIVER INTERNATIONAL (2013)
Retinol Binding Protein-4 Circulating Levels Were Higher in Nonalcoholic Fatty Liver Disease Vs. Histologically Normal Liver from Morbidly Obese Women
Ximena Terra et al.
OBESITY (2013)
Alterations in Adipocytokines and cGMP Homeostasis in Morbid Obesity Patients Reverse After Bariatric Surgery
Vicente Felipo et al.
OBESITY (2013)
Association between Serum Leptin Concentrations and Insulin Resistance: A Population-Based Study from China
Hui Zuo et al.
PLOS ONE (2013)
Quercetin ameliorate insulin resistance and up-regulates cellular antioxidants during oleic acid induced hepatic steatosis in HepG2 cells
Satyakumar Vidyashankar et al.
TOXICOLOGY IN VITRO (2013)
Fructose as a key player in the development of fatty liver disease
Metin Basaranoglu et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
What is the role of adiponectin in obesity related non-alcoholic fatty liver disease?
Carmine Finelli et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
From fatty liver to fibrosis: A tale of second hit
Metin Basaranoglu et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
Pathogenesis of hepatic steatosis: The link between hypercortisolism and non-alcoholic fatty liver disease
Giovanni Tarantino et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
Effects of probiotics on nonalcoholic fatty liver disease: A meta-analysis
Yan-Yan Ma et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
Obesity as the common soil of non-alcoholic fatty liver disease and diabetes: Role of adipokines
Elaine Hui et al.
JOURNAL OF DIABETES INVESTIGATION (2013)
Tumor Necrosis Factor-α as a Predictor for the Development of Nonalcoholic Fatty Liver Disease: A 4-Year Follow-Up Study
Yun Yong Seo et al.
ENDOCRINOLOGY AND METABOLISM (2013)
Metabolic Risk Susceptibility in Men Is Partially Related to Adiponectin/Leptin Ratio
Gloria Lena Vega et al.
JOURNAL OF OBESITY (2013)
Administration of ghrelin improves inflammation, oxidative stress, and apoptosis during and after non-alcoholic fatty liver disease development
Yan Li et al.
ENDOCRINE (2013)
cDNA Cloning and Expression of a Novel Adipose Specific Collagen-like Factor, apM1 (Adipose Most Abundant Gene Transcript 1) (Reprinted from BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, vol 221, pg 286-289, 1996)
Kazuhisa Maeda et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
New insights into the impact of the intestinal microbiota on health and disease: a symposium report
Linda V. Thomas et al.
BRITISH JOURNAL OF NUTRITION (2012)
The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology
Naga Chalasani et al.
GASTROENTEROLOGY (2012)
Relationship Between Leptin G2548A and Leptin Receptor Q223R Gene Polymorphisms and Obesity and Metabolic Syndrome Risk in Tunisian Volunteers
Imen Boumaiza et al.
GENETIC TESTING AND MOLECULAR BIOMARKERS (2012)
Metabolic adaptation to a high-fat diet is associated with a change in the gut microbiota
Matteo Serino et al.
GUT (2012)
Association of tumor necrosis factor-a gene promoter polymorphism at sites-308 and-238 with non-alcoholic fatty liver disease: A meta-analysis
Ji-kai Wang et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2012)
Serum interleukin 1 receptor antagonist as an independent marker off non-alcoholic steatohepatitis in humans
Jussi Pihlajamaki et al.
JOURNAL OF HEPATOLOGY (2012)
Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10-/- mice
Suzanne Devkota et al.
NATURE (2012)
The Impact of Leptin and Adiponectin on Incident Type 2 Diabetes Is Modified by Sex and Insulin Resistance
Mikael Lilja et al.
METABOLIC SYNDROME AND RELATED DISORDERS (2012)
Fish oil improves lipid metabolism and ameliorates inflammation in patients with metabolic syndrome: Impact of nonalcoholic fatty liver disease
Mohammed M. H. Al-Gayyar et al.
PHARMACEUTICAL BIOLOGY (2012)
Genetically modified mouse models for the study of nonalcoholic fatty liver disease
Perumal Nagarajan et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2012)
Animal models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
Yoshihisa Takahashi et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2012)
Role of cytokines and chemokines in non-alcoholic fatty liver disease
Vincent Braunersreuther et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2012)
Role of Adipokines and Other Inflammatory Mediators in Gestational Diabetes Mellitus and Previous Gestational Diabetes Mellitus
Nikolaos Vrachnis et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2012)
Is the Gut Microbiota a New Factor Contributing to Obesity and Its Metabolic Disorders?
Kristina Harris et al.
JOURNAL OF OBESITY (2012)
Analysis of adipokine concentrations in paediatric non-alcoholic fatty liver disease
E. Fitzpatrick et al.
PEDIATRIC OBESITY (2012)
TNF-α messenger ribonucleic acid (mRNA) in patients with nonalcoholic steatohepatitis
Nada Alaaeddine et al.
EUROPEAN CYTOKINE NETWORK (2012)
Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults
G. Vernon et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
High liver RBP4 protein content is associated with histological features in patients with genotype 1 chronic hepatitis C and with nonalcoholic steatohepatitis
Salvatore Petta et al.
DIGESTIVE AND LIVER DISEASE (2011)
Lack of interleukin-1α or interleukin-1β inhibits transformation of steatosis to steatohepatitis and liver fibrosis in hypercholesterolemic mice
Yehuda Kamari et al.
JOURNAL OF HEPATOLOGY (2011)
Role of tumor necrosis factor α (TNFα) in the onset of fructose-induced nonalcoholic fatty liver disease in mice
Giridhar Kanuri et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2011)
Blockade of IL-6 signaling exacerbates liver injury and suppresses antiapoptotic gene expression in methionine choline-deficient diet-Fed db/db mice
Kanji Yamaguchi et al.
LABORATORY INVESTIGATION (2011)
Adipose and Liver Expression of Interleukin (IL)-1 Family Members in Morbid Obesity and Effects of Weight Loss
Alexander R. Moschen et al.
MOLECULAR MEDICINE (2011)
Association of Obestatin, Ghrelin, and Inflammatory Cytokines in Obese Patients with Non-alcoholic Fatty Liver Disease
Michael Estep et al.
OBESITY SURGERY (2011)
Dietary Oleate Has Beneficial Effects on Every Step of Non-Alcoholic Fatty Liver Disease Progression in a Methionine- and Choline-Deficient Diet-Fed Animal Model
Ji Young Lee et al.
DIABETES & METABOLISM JOURNAL (2011)
Serotonin reuptake transporter (SERT) plays a critical role in the onset of fructose-induced hepatic steatosis in mice
Synia Haub et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2010)
Interleukin-6 Signaling in Liver-Parenchymal Cells Suppresses Hepatic Inflammation and Improves Systemic Insulin Action
F. Thomas Wunderlich et al.
CELL METABOLISM (2010)
Disruption of Hepatic Leptin Signaling Protects Mice From Age- and Diet-Related Glucose Intolerance
Frank K. Huynh et al.
DIABETES (2010)
Serum retinol-binding protein 4 in patients with nonalcoholic fatty liver disease: does it have a significant impact on pathogenesis?
Cem Cengiz et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2010)
Toll-Like Receptor 9 Promotes Steatohepatitis by Induction of Interleukin-1β in Mice
Kouichi Miura et al.
GASTROENTEROLOGY (2010)
Kupffer Cells Promote Hepatic Steatosis Via Interleukin-1β-Dependent Suppression of Peroxisome Proliferator-Activated Receptor α Activity
Rinke Stienstra et al.
HEPATOLOGY (2010)
Adiponectin Activation of AMPK Disrupts Leptin-Mediated Hepatic Fibrosis via Suppressors of Cytokine Signaling (SOCS-3)
Jeffrey A. Handy et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2010)
PARP1 deficiency exacerbates diet-induced obesity in mice
Kishor Devalaraja-Narashimha et al.
JOURNAL OF ENDOCRINOLOGY (2010)
Protective effect of bile acids on the onset of fructose-induced hepatic steatosis in mice
Valentina Volynets et al.
JOURNAL OF LIPID RESEARCH (2010)
Dietary α- and γ-tocopherol supplementation attenuates lipopolysaccharide-induced oxidative stress and inflammatory-related responses in an obese mouse model of nonalcoholic steatohepatitis
Min-Yu Chung et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2010)
Endotoxin and Plasminogen Activator Inhibitor-1 Serum Levels Associated With Nonalcoholic Steatohepatitis in Children
Anna Alisi et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2010)
Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome
E. Maury et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2010)
Blockade of interleukin-6 signaling enhances hepatic steatosis but improves liver injury in methionine choline-deficient diet-fed mice
Kanji Yamaguchi et al.
LABORATORY INVESTIGATION (2010)
The role of hepatic fat accumulation in pathogenesis of non-alcoholic fatty liver disease (NAFLD)
Qing Liu et al.
LIPIDS IN HEALTH AND DISEASE (2010)
The immunosuppressant drug, thalidomide, improves hepatic alterations induced by a high-fat diet in mice
Livia de Fraia Pinto et al.
LIVER INTERNATIONAL (2010)
Increased Soluble Leptin Receptor Levels in Morbidly Obese Patients With Insulin Resistance and Nonalcoholic Fatty Liver Disease
Valentina Medici et al.
OBESITY (2010)
Hyperleptinemia Is Required for the Development of Leptin Resistance
Zachary A. Knight et al.
PLOS ONE (2010)
Circulating levels of interleukin-18 in patients with non-alcoholic fatty liver disease
Serkan Tapan et al.
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION (2010)
Leptin resistance: a prediposing factor for diet-induced obesity
Philip J. Scarpace et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2009)
Adiponectin suppresses hepatic SREBP1c expression in an AdipoR1/LKB1/AMPK dependent pathway
Motoharu Awazawa et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
The metabolic syndrome: how it may influence hepatic stellate cell activation and hepatic fibrosis
Nicolas Lanthier et al.
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE (2009)
Genetic polymorphisms in non-alcoholic fatty liver disease: Interleukin-6-174G/C polymorphism is associated with non-alcoholic steatohepatitis
L. Carulli et al.
DIGESTIVE AND LIVER DISEASE (2009)
Influence of Visfatin on Histopathological Changes of Non-alcoholic Fatty Liver Disease
R. Aller et al.
DIGESTIVE DISEASES AND SCIENCES (2009)
Acylated and nonacylated ghrelin levels and their associations with insulin resistance in obese and normal weight children with metabolic syndrome
Lucia Pacifico et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2009)
Could inflammatory markers help diagnose nonalcoholic steatohepatitis?
Giovanni Tarantino et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2009)
Antiapoptotic Effect of c-Jun N-terminal Kinase-1 through Mcl-1 Stabilization in TNF-Induced Hepatocyte Apoptosis
Yijz Kodama et al.
GASTROENTEROLOGY (2009)
Increased Intestinal Permeability and Tight Junction Alterations in Nonalcoholic Fatty Liver Disease
Luca Miele et al.
HEPATOLOGY (2009)
Toll-Like Receptor 4 Is Involved in the Development of Fructose-Induced Hepatic Steatosis in Mice
Astrid Spruss et al.
HEPATOLOGY (2009)
Circulating and liver tissue levels of retinol-binding protein-4 in non-alcoholic fatty liver disease
Maria Schina et al.
HEPATOLOGY RESEARCH (2009)
Acylated and desacyl ghrelin stimulate lipid accumulation in human visceral adipocytes
A. Rodriguez et al.
INTERNATIONAL JOURNAL OF OBESITY (2009)
Serum Retinol-binding Protein 4 Levels in Patients With Nonalcoholic Fatty Liver Disease
Naim Alkhouri et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2009)
Expression of adiponectin and its receptors in livers of morbidly obese patients with non-alcoholic fatty liver disease
Hong Ma et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2009)
Serum adipokine levels predictive of liver injury in non-alcoholic fatty liver disease
Maud Lemoine et al.
LIVER INTERNATIONAL (2009)
Adipokines in Nonalcoholic Steatohepatitis: From Pathogenesis to Implications in Diagnosis and Therapy
Emmanuel A. Tsochatzis et al.
MEDIATORS OF INFLAMMATION (2009)
Liver NF-κB and AP-1 DNA Binding in Obese Patients
Luis A. Videla et al.
OBESITY (2009)
Pattern of Expression of Adiponectin Receptors in Human Liver and its Relation to Nonalcoholic Steatohepatitis
M. Nannipieri et al.
OBESITY SURGERY (2009)
Adiponectin in health and disease: evaluation of adiponectin-targeted drug development strategies
Shoba Shetty et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2009)
Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis
Anna Wieckowska et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Post-translational modifications of adiponectin: mechanisms and functional implications
Yu Wang et al.
BIOCHEMICAL JOURNAL (2008)
Identification of the acyltransferase that octanoylates ghrelin, an appetite-stimulating peptide hormone
Jing Yang et al.
CELL (2008)
Treatment with an Interleukin 1 beta antibody improves glycemic control in diet-induced obesity
O. Osborn et al.
CYTOKINE (2008)
Total adiponectin and adiponectin multimeric complexes in relation to weight loss-induced improvements in insulin sensitivity in obese women: the NUGENOB study
J. Polak et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2008)
Retinol-binding protein 4 is associated with insulin resistance, but appears unsuited for metabolic screening in women with polycystic ovary syndrome
Matthias Moehlig et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2008)
Reduced response to adiponectin and lower abundance of adiponectin receptor proteins in type 2 diabetic monocytes
Johanna Weigert et al.
FEBS LETTERS (2008)
Inflammatory stress exacerbates lipid accumulation in hepatic cells and fatty livers of apolipoprotein E knockout mice
Kun L. Ma et al.
HEPATOLOGY (2008)
Antibiotics protect against fructose-induced hepatic lipid accumulation in mice:: Role of endotoxin
Ina Bergheim et al.
JOURNAL OF HEPATOLOGY (2008)
Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial
Josef S. Smolen et al.
LANCET (2008)
Effect of leptin infusion on insulin sensitivity and lipid metabolism in diet-induced lipodystrophy model mice
Koji Nagao et al.
LIPIDS IN HEALTH AND DISEASE (2008)
Serum adipokine levels in chronic liver diseases: Association of resistin levels with fibrosis severity
Emmanuel Tsochatzis et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2008)
Inhibition of hepatic interleukin-18 production by rosiglitazone in a rat model of nonalcoholic fatty liver disease
Hai-Ning Wang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
Increased plasma visfatin levels in subjects with the metabolic syndrome
T. D. Filippatos et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2008)
Macrophage-adipocyte interaction: Marked interleukin-6 production by lipopolysaccharide
Akiko Yamashita et al.
OBESITY (2007)
Effects of pentoxifylline on TNF-α production by peripheral blood mononuclear cells in patients with nonalcoholic steatohepatitis
Deniz G. Duman et al.
DIGESTIVE DISEASES AND SCIENCES (2007)
Infliximab reverses steatosis and improves insulin signal transduction in liver of rats fed a high-fat diet
Raquel Barbuio et al.
JOURNAL OF ENDOCRINOLOGY (2007)
High-sensitivity C-reactive protein is an independent clinical feature of nonalcoholic steatohepatitis (NASH) and also of the severity of fibrosis in NASH
Masato Yoneda et al.
JOURNAL OF GASTROENTEROLOGY (2007)
Correlation of serum TNF-α levels and histologic liver injury scores in pediatric nonalcoholic fatty liver disease
Melania Manco et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2007)
Beneficial effects of pentoxifylline on hepatic steatosis, fibrosis and necroinflammation in patients with non-alcoholic steatohepatitis
Sanjaya K. Satapathy et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2007)
IL-6 and IGF-1 are independent prognostic factors of liver steatosis and non-alcoholic steatohepatitis in morbidly obese patients
David Garcia-Galiano et al.
OBESITY SURGERY (2007)
Interleukin-1 beta-induced insulin resistance in adipocytes through down-regulation of insulin receptor substrate-1 expression
Jennifer Jager et al.
ENDOCRINOLOGY (2007)
Influence of TNF gene polymorphisms in Japanese patients with NASH and simple steatosis
Katsutoshi Tokushige et al.
JOURNAL OF HEPATOLOGY (2007)
Long-term treatment with interleukin-1β induces insulin resistance in murine and human adipocytes
C. Lagathu et al.
DIABETOLOGIA (2006)
Interleukin-6 is a key mediator of the hepatoprotective and pro-proliferative effects of ischaemic preconditioning in mice
Narci Teoh et al.
JOURNAL OF HEPATOLOGY (2006)
Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2
John Willy Haukeland et al.
JOURNAL OF HEPATOLOGY (2006)
Interleukin-1 beta up-regulates tissue inhibitor of matrix metal loproteinase-1 mRNA and phosphorylation of c-jun N-terminal kinase and p38 in hepatic stellate cells
Ya-Ping Zhang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2006)
Tumour necrosis factor α signalling through activation of Kupffer cells plays an essential role in liver fibrosis of non-alcoholic steatohepatitis in mice
K Tomita et al.
GUT (2006)
Paradoxical effects of short- and long-term interleukin-6 exposure on liver injury and repair
XL Jin et al.
HEPATOLOGY (2006)
Interleukin-1 receptor antagonist is upregulated during diet-induced obesity and regulates insulin sensitivity in rodents
E Somm et al.
DIABETOLOGIA (2006)
Serum cytokine and soluble cytokine receptor levels in patients with non-alcoholic steatohepatitis
S Abiru et al.
LIVER INTERNATIONAL (2006)
Interleukin-1 alpha inhibits insulin signaling with phosphorylating insulin receptor substrate-1 on serine residues in 3T3-L1 adipocytes
JY He et al.
MOLECULAR ENDOCRINOLOGY (2006)
Elevated plasma interleukin-18 is a marker of insulin-resistance in type 2 diabetic and non-diabetic humans
CP Fischer et al.
CLINICAL IMMUNOLOGY (2005)
NF-κB activation, rather than TNF, mediates hepatic inflammation in a murine dietary model of steatohepatitis
A Dela Peña et al.
GASTROENTEROLOGY (2005)
Tumor necrosis factor-α induces skeletal muscle insulin resistance in healthy human subjects via inhibition of Akt substrate 160 phosphorylation
P Plomgaard et al.
DIABETES (2005)
Interleukin-6 depletion selectively improves hepatic insulin action in obesity
PJ Klover et al.
ENDOCRINOLOGY (2005)
Deficiency of interleukin-1 receptor antagonist deteriorates fatty liver and cholesterol metabolism in hypercholesterolemic mice
K Isoda et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Beyond insulin resistance in NASH:: TNF-α or adiponectin?
JM Hui et al.
HEPATOLOGY (2004)
A pilot trial of pentoxifylline in nonalcoholic steatohepatitis
LA Adams et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2004)
Beneficial effects of tumor necrosis factor-α inhibition by pentoxifylline on clinical, biochemical, and metabolic parameters of patients with nonalcoholic steatohepatitis
SK Satapathy et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2004)
Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-α, overexpressed in human fat cells from insulin-resistant subjects
V Rotter et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Cytokines and NASH: A pilot study of the effects of lifestyle modification and vitamin E
M Kugelmas et al.
HEPATOLOGY (2003)
Impact of weight loss on inflammatory proteins and their association with the insulin resistance syndrome in morbidly obese patients
HP Kopp et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)
Suppressor of cytokine signaling-3 (SOCS-3), a potential mediator of interleukin-6-dependent insulin resistance in hepatocytes
JJ Senn et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Lack of interleukin-1β decreases the severity of atherosclerosis in ApoE-deficient mice
H Kirii et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)
Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease
ZP Li et al.
HEPATOLOGY (2003)
Chronic exposure to interleukin-6 causes hepatic insulin resistance in mice
PJ Klover et al.
DIABETES (2003)
Interleukin-6 induces cellular insulin resistance in hepatocytes
JJ Senn et al.
DIABETES (2002)
C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus
AD Pradhan et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
IL-18 and IL-12 induce intestinal inflammation and fatty liver in mice in an IFN-γ dependent manner
S Chikano et al.
GUT (2000)
Plasma interleukin-6, tumour necrosis factor α and blood cytokine production in type 2 diabetes
JC Pickup et al.
LIFE SCIENCES (2000)
分享论文
